# OPDIVO QVANTIG
> **BLA761381** · Biologics License Application · Sponsor: BRISTOL-MYERS SQUIBB · Approved 2024-12-27
## Drug
- **FDA Application Number:** BLA761381
- **Application type:** Biologics License Application
- **Brand name:** OPDIVO QVANTIG
- **Generic name:** NIVOLUMAB AND HYALURONIDASE-NVHY
- **Active ingredients:** NIVOLUMAB; HYALURONIDASE-NVHY
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** BRISTOL-MYERS SQUIBB
- **Manufacturer:** E.R. Squibb & Sons, L.L.C.
- **First approval:** 2024-12-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761381)
---
*MORVS · CC0 1.0*